Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (295)
- Advertising (25)
- Safety monitoring and information (23)
- Manufacturing (11)
- Scheduling (national classification system) (10)
- COVID-19 (7)
- Clinical trials (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
567 result(s) found, displaying 301 to 325
-
Meeting statementsCommunique from the meeting of the TGACC
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 19 March 2020
-
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Corporate reportsStatistical information for 1 July to 31 December 2019 in relation to our regulation of therapeutic goods
-
Corporate reportsIn 2019, the TGA conducted 10 pharmacovigilance inspections of Australian medicine sponsors
-
Meeting statementsThe TGACC meeting was held on 20 Feb 2020, a communique has been published
-
Corporate reportsThis report describes the first 12 months of the mandatory reporting scheme
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper.
-
Meeting statementsThe Advisory Committee on Biologicals (ACB) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990
-
Meeting statementsThe Advisory Committee on Biologicals (ACB) is a statutory advisory committee established by the Therapeutic Goods Regulations 1990.
-
Corporate reportsThe Health Products Regulation Group has published a new regulatory science strategy
-
Corporate reportsOur plan for how HPRG will maintain and build its regulatory science capability over the next 5 years
-
Corporate reportsThe TGA has finalised the outcomes of the Lower Risk Registered OTC Products Review Pilot Project
-
Corporate reportsTGA instructions for disinfectant testing.
-
Corporate reportsTargets have been met for most measures under the six KPIs
-
Corporate reportsRegulatory Impact Self-Assessment Report
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 27 November 2019
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 26 July 2019
-
Corporate reportsThe TGA thanks respondents who provided a submission in response to the public consultation paper
-
Corporate reportsThe TGA has conducted a safety review on coumarin in topical listed medicines
-
Corporate reportsOn Monday, 2 December 2019, a TGA Progress Report to the Senate Mesh Inquiry was tabled in the Senate
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsFurther comments received on the consultation